On-line microcolumn-based dynamic leaching method for investigation of lead bioaccessibility in shooting range soils.

In this work, a miniaturized flow-through leaching test is presented for rapid screening of potential chemical extractants to explore the bioaccessibility of lead (Pb) in contaminated shooting range soils in Valkeala, Finland. The method combines the versatility of microcolumn-based extraction methods with on-line inductively coupled plasma optical emission spectrometry (ICP OES) analysis for expedient assessment of the magnitude of the bioaccessible pools and the leaching kinetics of lead from polluted soils under variable physicochemical scenarios. Acids and salt solutions were studied as potential extractants. The efficiency of the extractants relative to the initial total amount of lead in the soil sample (509 ± 21 mg/kg) were found to increase in the following order: 0.11 M acetic acid (55%) < 1 M MgCl2 (58%) < 0.1 M NH2OH·HCl (61%) < 0.1 M citric acid (93%) < 0.1 M HCl (96%). The proposed on-line microcolumn-based method was further explored for implementation of the modified BCR (now termed Standards, Measurements and Testing Programme, SM&T) sequential extraction procedure to avail the information about different fractions available in the solid sample, and validated by mass balance calculations. The equivalent sequential procedure in a batch format was then studied and compared against the on-line microcolumn extraction method. The on-line dynamic extraction system presented in this work accepts a substantial amount of sample (2.5 g) as compared to previous flow-through mini-column setups (generally accommodating < 0.25 g of sample), thus maintaining sample representativeness and fostering comprehension of the extraction patterns for non-homogenous soil materials. The use of cotton buds and Teflon membranes and holders in the microcolumn setup facilitates the repeatable flow-through leaching of trace elements and restrict formation of preferential channels. Monitoring of the leachable trace elements in real time delivers detailed insight into the ongoing extraction process and provides a time-saving assessment of potential chemical extractants.

Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.

PURPOSE: To quantitate gadolinium deposits in gliomas and adjacent normal brain specimens, and to evaluate their association with tumor contrast enhancement and the type of gadolinium-based contrast agent (GBCA) used. METHODS: A total of 69 patients with primary glioma who underwent contrast-enhanced magnetic resonance imaging (MRI) prior to surgery were included in this retrospective study. Gadolinium was measured from histologically viable tumor, normal brain, and necrosis within the sample, when available, using inductively coupled plasma mass spectrometry (ICP-MS). Tumor contrast enhancement was categorized as none, minimal, or noticeable. Differences in gadolinium deposits by contrast enhancement and GBCA type were assessed. RESULTS: Seven patients received linear GBCA and 62 macrocyclic, respectively. At the time of surgery, gadolinium deposits were detected in 39 out of 69 (57%) tumor samples, 8 out of 13 (62%) normal brain, and 12 out of 14 (86%) necrotic specimens. Gadolinium was detected in both enhancing and non-enhancing tumors, but was greatest in gliomas with noticeable enhancement (p = 0.02). Administration of linear agents gadodiamide and gadopentetate dimeglumine resulted in significantly higher tumor gadolinium relative to macrocyclic gadoterate meglumine (p < 0.01 and p < 0.05, respectively). Normal brain and necrosis also showed higher gadolinium after exposure to linear gadodiamide (both p < 0.05). In multivariate regression, GBCA type (linear/macrocyclic) was the most powerful predictor of tumor gadolinium retention (p < 0.001). CONCLUSION: Gadolinium can be detected in both enhancing and non-enhancing gliomas, neighboring normal brain, and necrosis. Gadolinium retention is higher after exposure to linear GBCAs compared with the macrocyclic gadoterate meglumine.

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Nanotechnology has attracted considerable interest in the field of biomedicine, where various nanoparticles (NPs) have been introduced as efficient drug carrier systems. Mesoporous silicon (PSi) is one of the most promising materials in this field due to its low toxicity, good biodegradability, high surface area, tunable pore size and controllable surface functionality. However, recognition by the reticuloendothelial system and particle agglomeration hinder the use of PSi for intravenous applications. The present paper describes a dual-PEGylation method, where two PEG molecules with different sizes (0.5 and 2 kDa) were grafted simultaneously in a single process onto thermally oxidized PSi NPs to form a high-density PEG coating with both brush-like and mushroom-like conformation. The material was characterized in detail and the effects of the dual-PEGylation on cell viability, protein adsorption and macrophage uptakes were evaluated. The results show that dual-PEGylation improves the colloidal stability of the NPs in salt solutions, prolongs their half-lives, and minimizes both protein adsorption and macrophage uptake. Therefore, these new dual-PEGylated PSi NPs are potential candidates for intravenous applications.